News

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High ...
26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...
17 June 2025 Ex-co-head of life sciences at previous firm brings expertise in multi-jurisdictional patent disputes involving ...
French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...
This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...
Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and ...
Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of ...